Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.
6d
Everyday Health on MSNFDA Expands Access to Clozapine for Treatment-Resistant SchizophreniaPatients will no longer need to provide blood test results before they can get clozapine prescriptions filled, according to ...
The symptoms of schizophrenia vary greatly from person to person. A new study appearing in the American Journal of Psychiatry ...
The subtleties involved here reflect the fact that the brain’s dizzying complexity means it’s rarely possible to draw simple ...
A new study has revealed that schizophrenia manifests differently in each person, with variations in brain structure ...
Researchers analyzed thousands of brain scans to uncover how schizophrenia varies at a structural level. While some brain ...
The FDA has eliminated the need for pharmacists to verify a patient's white blood cell count before dispensing the antipsychotic medication clozapine.
The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.
Study finds the biological heterogeneity of schizophrenia is reflected in structural irregularities of the brain as well as functional abnormalities.
Schizophrenia and bipolar disorder are severe mental disorders that often manifest in early adulthood. Effective treatments ...
A new international study reveals that schizophrenia manifests differently in the brain, reflecting the wide range of symptoms among patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results